New Current Report Filed with the SEC Disclosing Occurrence of a Triggering Event That Accelerates or Increases a Financial Obligation: 8-K – Immune Therapeutics, Inc. (0001559356) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing the occurrence of an event that triggers the acceleration of or increase in a direct financial obligation or an obligation under an off-balance sheet arrangement. Details of the current report are:

8-K – Immune Therapeutics, Inc. (0001559356) (Filer)
Filed: 2016-12-14 AccNo: 0001493152-16-015851 Size: 23 KB

Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Filing Date: 2016-12-13T21:50:14-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1559356/000149315216015851/0001493152-16-015851-index.htm